FDA warns former Sun Pharma U.S. drug factory over quality concerns

MUMBAI (Reuters) - The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.